An Alzheimer’s Drug Shows Serious Promise
Treating Alzheimer’s likely won’t ever be an easy or simple thing. Researchers think that managing the disease will require a combination of treatments, possibly tailored to each person. But in a paper published Wednesday in the journal Nature, scientists from a biotech company report the most encouraging results so far for one drug that could play a key role./.../
++++++++++++++++++++++++++++++++
Alzheimer's Drug Shows Promise in Small Trial
Patients who received the antibody therapy had reduced levels of amyloid protein in their brains after one year
\PET images of Alzheimer’s patients receiving aducanumab, showing amyloid plaque reduction after one year. Credit: SEVIGNY et al
A new drug trial that some researchers are calling the most promising yet in the fight against Alzheimer’s suggests it may be possible to clear the brain of the amyloid protein that is characteristic of the disease.
No comments:
Post a Comment